However, recent findings suggest that these antibodies may also mediate antibody-dependent cellular cytotoxicity/phagocytosis (ADCC/P), leading to Treg depletion and enhancing CD8+T cell responses specific to tumor antigens (110). This evidence concerns the gene CD8A and neoplasm.